Ex-poll chair Brillantes intubated in Medical Center Manila due to COVID-19 | Inquirer News

Ex-poll chair Brillantes intubated in Medical Center Manila due to COVID-19

By: - Reporter / @ConsINQ
/ 12:27 AM July 26, 2020

MANILA, Philippines — Former Commission on Elections (Comelec) Chairman Sixto Brillantes Jr. was intubated at the Medical Center Manila on Saturday afternoon after testing positive for COVID-19.

“Given that his oxygen level is not stable despite all types of medication & convalescent plasma, his doctors found it best to intubate him this afternoon,” Zeena Brillantes, the former Comelec chair’s daughter, said via Facebook Messenger when asked about the condition of her father.

Zeena said her father was confined at the hospital on July 18 after showing signs of pneumonia. On July 22, test results confirmed that Brillantes as having COVID-19.

Article continues after this advertisement

It was not immediately disclosed where Sixto contracted the new virus, Zeena added.

FEATURED STORIES

“Because he has been going to his office the past 2-3 weeks prior to hospitalization, we do not know where he contracted the virus,” she said.

In a public post, Zeena asked the public for prayers.

Article continues after this advertisement

Brillantes was appointed as Comelec chair in 2011 by then-President Benigno Aquino III.

Article continues after this advertisement

/atm

https://www.facebook.com/photo.php?fbid=10159434456989672&set=a.10150102404069672&type=3

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Comelec, coronavirus Philippines

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.